MCHP
43
-6
ADP
69
-3
NTRS
49
-5
ALLE
57
-7
DOW
58
-5
MLM
53
-5
C
60
-2
SO
66
2
VRSK
35
-3
EL
30
-3
SCHW
52
3
AVB
65
-2
KHC
59
14
LLY
48
-2
ADT
32
9
MAS
67
-3
LH
48
-2
IP
39
-6
XRX
52
-3
ACN
56
13
MCHP
43
-6
ADP
69
-3
NTRS
49
-5
ALLE
57
-7
DOW
58
-5
MLM
53
-5
C
60
-2
SO
66
2
VRSK
35
-3
EL
30
-3
SCHW
52
3
AVB
65
-2
KHC
59
14
LLY
48
-2
ADT
32
9
MAS
67
-3
LH
48
-2
IP
39
-6
XRX
52
-3
ACN
56
13
Financhill
Back

NewAmsterdam Pharma Co NV Vs. ProQR Therapeutics NV Industry Stock Comparison

Sell
23

NAMS
NewAmsterdam Pharma Co NV

Last Price:
15.90
Seasonality Move:
4.65%
Sell
25

PRQR
ProQR Therapeutics NV

Last Price:
1.72
Seasonality Move:
-1.1%
Sell
23
NewAmsterdam Pharma Co NV (NAMS) is a Sell

Is NewAmsterdam Pharma Co NV a Buy, Sell or Hold?

  • The current NewAmsterdam Pharma Co NV [NAMS] share price is $15.88. The Score for NAMS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NAMS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
ProQR Therapeutics NV (PRQR) is a Sell

Is ProQR Therapeutics NV a Buy, Sell or Hold?

  • The current ProQR Therapeutics NV [PRQR] share price is $1.73. The Score for PRQR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NAMS Stock Price Chart

What is NewAmsterdam Pharma Co NV's stock price today?

  • The NewAmsterdam Pharma Co NV share price today is $15.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAMS is experiencing selling pressure, which indicates risk of future bearish movement.

PRQR Stock Price Chart

What is ProQR Therapeutics NV's stock price today?

  • The ProQR Therapeutics NV share price today is $1.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.

NAMS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 43.71 Sell
Chaikin Money Flow: -67635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.89 - 16.53) Sell
Bollinger Bands (100): (16.56 - 20.34) Sell

PRQR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 30.02 Sell
Chaikin Money Flow: -51308 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.81 - 2.07) Sell
Bollinger Bands (100): (1.74 - 2.02) Sell

NAMS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.91 Sell
20-day SMA: 16.19 Sell
50-day SMA: 16.99 Sell
200-day SMA: 18.51 Sell
8-day EMA: 15.96 Sell
20-day EMA: 16.2 Sell
50-day EMA: 16.97 Sell
200-day EMA: 17.31 Sell

PRQR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.82 Sell
20-day SMA: 1.9 Sell
50-day SMA: 1.92 Sell
200-day SMA: 1.99 Sell
8-day EMA: 1.81 Sell
20-day EMA: 1.87 Sell
50-day EMA: 1.9 Sell
200-day EMA: 1.91 Sell

NewAmsterdam Pharma Co NV Earnings Growth & NAMS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.19 per share, and an increase next year of $0.67 per share.

ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.

NewAmsterdam Pharma Co NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProQR Therapeutics NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):